* ProMIS Neurosciences Inc PMN.OQ PMN.O is expected
to show no
change in quarterly revenue when it reports results on November
12 (estimated) for the period ending September 30 2024
*
* LSEG's mean analyst estimate for ProMIS Neurosciences Inc
is
for a loss of 7 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for ProMIS
Neurosciences Inc is $8.75, above its last closing price
of $1.02.
This summary was machine generated November 8 at 15:46 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)